Cannara Announces Graduation to the Toronto Stock Exchange

Core Insights - Cannara Biotech Inc. has received final approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange, marking a significant milestone in its evolution as a public company [2] - The uplisting is expected to enhance market visibility and liquidity, broadening accessibility to institutional investors and reflecting the company's progress and commitment to long-term shareholder value [2] Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec that span over 1,600,000 square feet [4] - The company has a potential annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to produce affordable premium-grade cannabis products [4] Trading Information - The company's common shares will begin trading on the TSX under the symbol "LOVE" on March 2, 2026, with delisting from the TSXV effective the same day [2] - Cannara will celebrate its uplisting by opening the market at the TSX on March 17, 2026 [2] Coverage Initiation - TD Cowen has initiated coverage on Cannara as of February 24, 2026, with their research report available through their platform [3]